Annual ROE
-49.25%
-39.94%-429.00%
December 31, 2023
Summary
- As of February 7, 2025, NAMS annual return on equity is -49.25%, with the most recent change of -39.94% (-429.00%) on December 31, 2023.
- During the last 3 years, NAMS annual ROE has fallen by -209.97% (-130.64%).
- NAMS annual ROE is now -130.64% below its all-time high of 160.72%, reached on December 1, 2020.
Performance
NAMS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-51.66%
+6.37%+10.98%
September 30, 2024
Summary
- As of February 7, 2025, NAMS quarterly return on equity is -51.66%, with the most recent change of +6.37% (+10.98%) on September 30, 2024.
- Over the past year, NAMS quarterly ROE has dropped by -22.99% (-80.19%).
- NAMS quarterly ROE is now -416.60% below its all-time high of -10.00%, reached on December 31, 2022.
Performance
NAMS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NAMS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -429.0% | -80.2% |
| 3 y3 years | -130.6% | -416.6% |
| 5 y5 years | -130.6% | -416.6% |
NAMS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -429.0% | +33.5% | -416.6% | +19.5% |
| 5 y | 5-year | -130.6% | +33.5% | -416.6% | +19.5% |
| alltime | all time | -130.6% | +33.5% | -416.6% | +19.5% |
NewAmsterdam Pharma Company NV ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -51.66%(-11.0%) |
| Jun 2024 | - | -58.03%(-9.6%) |
| Mar 2024 | - | -64.17%(+3.5%) |
| Dec 2023 | -49.25% | -62.02%(+116.3%) |
| Sep 2023 | - | -28.67%(-35.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -44.71%(+231.2%) |
| Mar 2023 | - | -13.50%(+35.0%) |
| Dec 2022 | -9.31%(-87.4%) | -10.00% |
| Dec 2021 | -74.12%(-146.1%) | - |
| Dec 2020 | 160.72% | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual return on equity?
- What is the all time high annual ROE for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual ROE year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly return on equity?
- What is the all time high quarterly ROE for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly ROE year-on-year change?
What is NewAmsterdam Pharma Company NV annual return on equity?
The current annual ROE of NAMS is -49.25%
What is the all time high annual ROE for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual return on equity is 160.72%
What is NewAmsterdam Pharma Company NV annual ROE year-on-year change?
Over the past year, NAMS annual return on equity has changed by -39.94% (-429.00%)
What is NewAmsterdam Pharma Company NV quarterly return on equity?
The current quarterly ROE of NAMS is -51.66%
What is the all time high quarterly ROE for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly return on equity is -10.00%
What is NewAmsterdam Pharma Company NV quarterly ROE year-on-year change?
Over the past year, NAMS quarterly return on equity has changed by -22.99% (-80.19%)